164 related articles for article (PubMed ID: 1659595)
61. Cytomegalovirus seroconversion in patients receiving intensive induction therapy prior to allogeneic bone marrow transplantation.
Kelsey SM; Newland AC
Bone Marrow Transplant; 1989 Sep; 4(5):543-6. PubMed ID: 2551435
[TBL] [Abstract][Full Text] [Related]
62. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
Mabilangan C; Preiksaitis JK; Cervera C;
Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
[TBL] [Abstract][Full Text] [Related]
63. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
Pollard RB
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
[TBL] [Abstract][Full Text] [Related]
64. Cytomegalovirus infection in heart transplantation: A single center experience.
Echenique IA; Angarone MP; Rich JD; Anderson AS; Stosor V
Transpl Infect Dis; 2018 Aug; 20(4):e12896. PubMed ID: 29602266
[TBL] [Abstract][Full Text] [Related]
65. Transfusion-associated cytomegalovirus infections.
Adler SP
Rev Infect Dis; 1983; 5(6):977-93. PubMed ID: 6318291
[TBL] [Abstract][Full Text] [Related]
66. Role of CMV pneumonia in the development of obliterative bronchiolitis in heart-lung and double-lung transplant recipients.
Cerrina J; Le Roy Ladurie F; Herve PH; Parquin F; Harari S; Chapelier A; Simoneau G; Vouhe P; Dartevelle PH
Transpl Int; 1992; 5 Suppl 1():S242-5. PubMed ID: 14621790
[TBL] [Abstract][Full Text] [Related]
67. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine.
Dummer JS; White LT; Ho M; Griffith BP; Hardesty RL; Bahnson HT
J Infect Dis; 1985 Dec; 152(6):1182-91. PubMed ID: 2999255
[TBL] [Abstract][Full Text] [Related]
68. Cytomegalovirus infections and toxoplasmosis in heart transplant recipients in Sweden.
Andersson R; Sandberg T; Berglin E; Jeansson S
Scand J Infect Dis; 1992; 24(4):411-7. PubMed ID: 1329187
[TBL] [Abstract][Full Text] [Related]
69. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia.
Papazian L; Fraisse A; Garbe L; Zandotti C; Thomas P; Saux P; Pierrin G; Gouin F
Anesthesiology; 1996 Feb; 84(2):280-7. PubMed ID: 8602657
[TBL] [Abstract][Full Text] [Related]
70. Evaluation by immune scanning electron microscopy of foscarnet treatment of cytomegalovirus infection in patients with renal transplants.
Andersson J; Akesson-Johansson A; Brattström C
Scand J Infect Dis; 1989; 21(6):605-10. PubMed ID: 2559476
[TBL] [Abstract][Full Text] [Related]
71. Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy.
Wingard JR; Piantadosi S; Burns WH; Zahurak ML; Santos GW; Saral R
Rev Infect Dis; 1990; 12 Suppl 7():S793-804. PubMed ID: 2173108
[TBL] [Abstract][Full Text] [Related]
72. A multivariate analysis of the risk of cytomegalovirus infection in heart transplant recipients.
Gorensek MJ; Stewart RW; Keys TF; McHenry MC; Goormastic M
J Infect Dis; 1988 Mar; 157(3):515-22. PubMed ID: 2830344
[TBL] [Abstract][Full Text] [Related]
73. Transfusion-transmitted cytomegalovirus infections: significance and control.
Tegtmeier GE
Vox Sang; 1986; 51 Suppl 1():22-30. PubMed ID: 3017003
[TBL] [Abstract][Full Text] [Related]
74. Pulmonary Cytomegalovirus Replication in Renal Transplant Patients with Late Onset Pneumonitis.
Königshausen E; Hengel H; Adams O; Bry H; Steiner S; Priegnitz C; Hansen A; Sellin L; Rump LC; Voiculescu A
Ann Transplant; 2016 Apr; 21():235-40. PubMed ID: 27097869
[TBL] [Abstract][Full Text] [Related]
75. Foscarnet for cytomegalovirus pneumonitis.
Apperley JF; Marcus RE; Goldman JM; Wardle DG; Gravett PJ; Chanas A
Lancet; 1985 May; 1(8438):1151. PubMed ID: 2860348
[No Abstract] [Full Text] [Related]
76. Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients.
Klintmalm G; Lönnqvist B; Oberg B; Gahrton G; Lernestedt JO; Lundgren G; Ringdén O; Robert KH; Wahren B; Groth CG
Scand J Infect Dis; 1985; 17(2):157-63. PubMed ID: 2992074
[TBL] [Abstract][Full Text] [Related]
77. The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenous immunosuppression.
Preiksaitis JK; Brown L; McKenzie M
J Infect Dis; 1988 Mar; 157(3):523-9. PubMed ID: 2830345
[TBL] [Abstract][Full Text] [Related]
78. Cytomegalovirus as a cause of morbidity in heart transplantation. The experience of one center.
Steel HM; Murday AJ
Transplantation; 1996 Aug; 62(4):492-6. PubMed ID: 8781615
[TBL] [Abstract][Full Text] [Related]
79. Cytomegalovirus pneumonia in hematopoietic stem cell recipients.
Travi G; Pergam SA
J Intensive Care Med; 2014; 29(4):200-12. PubMed ID: 23753231
[TBL] [Abstract][Full Text] [Related]
80. Virologic and pathogenetic aspects of cytomegalovirus infection.
Grundy JE
Rev Infect Dis; 1990; 12 Suppl 7():S711-9. PubMed ID: 2173100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
